Correlation between mRNA expression level of the mutant COL4A5 gene and phenotypes of XLAS females

Experimental Biology and Medicine

Volumn 232, Issue 5, 2007, Pages 638-642

  Wang, Yunfeng ^a   Zhang, Hongwen ^a   Ding, Jie ^a   Wang, Fang ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Alport syndrome; Female; Messenger RNA; Phenotype; X inactivation

Indexed keywords

ANDROGEN RECEPTOR; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA5; MESSENGER RNA; POLYACRYLAMIDE GEL; UNCLASSIFIED DRUG;

ADULT; ALPORT SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; ELECTROPHORESIS; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HEMATURIA; HUMAN; HUMAN CELL; OPTICAL DENSITY; PHENOTYPIC VARIATION; PROTEINURIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKED DISORDER;

ADULT; CELLS, CULTURED; COLLAGEN TYPE IV; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FIBROBLASTS; GENE EXPRESSION; HEMATURIA; HUMANS; MUTATION; NEPHRITIS, HEREDITARY; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; X CHROMOSOME INACTIVATION;

EID: 34247585168     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M. Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant 17:1218-1227, 2002.
2. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 348:2543-2556, 2003.
3. Kashtan CE. Alport syndromes. Phenotypic heterogeneity of progressive hereditary nephritis. Pediatr Nephrol 14:502-512, 2000.
4. Meleg-Smith S, Magliato S, Cheles M, Garola RE, Kashtan CE. Xlinked Alport syndrome in females. Hum Pathol 29:404-408, 1998.
5. Flinter FA, Cameron JS, Chantler C, Houston I, Bobrow M. Genetics of classic Alport's syndrome. Lancet 2:1005-1007, 1988.
6. Mazzucco G, Barsotti P, Muda AO, Fortunato M, Mihatsch M, Torri-Tarelli L, Renieri A, Faraggiana T, De Marchi M, Monga G. Ultrastructural and immunohistochemical findings in Alport's syndrome: a study of 108 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations. J Am Soc Nephrol 9:1023-1031, 1998.
7. Wang F, Ding J, Guo S, Yang J. Phenotypic and genotypic features of Alport syndrome in Chinese children. Pediatr Nephrol 17:1013-1020, 2002.
8. van der Loop FT, Monnens LA, Schroder CH, Lemmink HH, Breuning MH, Timmer ED, Smeets HJ. Identification of COL4A5 defects in Alport's syndrome by immunohistochemistry of skin. Kidney Int 55:1217-1224, 1999.
9. Wang F, Wang Y, Ding J, Yang J. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts. Kidney Int 67:1268-1274, 2005.
10. Zhou J, Leinonen A, Tryggvason K. Structure of the human type IV collagen COL4A5 gene. J Biol Chem 269:6608-6614, 1994.
11. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229-239, 1992.
12. Hatakeyama C, Anderson CL, Beever CL, Penaherrera MS, Brown CJ, Robinson WP. The dynamics of X-inactivation skewing as women age. Clin Genet 66:327-332, 2004.
13. Kristiansen M, Knudsen GP, Tanner SM, McEntagart M, Jungbluth H, Muntoni F, Sewry C, Gallati S, Orstavik KH, Wallgren-Pettersson C. X-inactivation patterns in carriers of X-linked myotubular myopathy. Neuromuscul Disord 13:468-471, 2003.
14. Calvo RM, Asuncion M, Sancho J, San Millan JL, Escobar-Morreale HF. The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogensis of hirsutism. J Clin Endocrinol Metab 85:1735-1740, 2000.
15. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study. J Am Soc Nephrol 14:2603-2610, 2003.
16. Guo C, Van Damme B, Vanrenterghem Y, Devriendt K, Cassiman JJ, Marynen P. Severe Alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele. J Clin Invest 95:1832-1837, 1995.
17. Grunfeld JP, Noel LH, Hafez S, Droz D. Renal prognosis in women with hereditary nephritis. Clin Nephrol 23:267-271, 1985.
18. Andreu N, Pujol-Moix N, Martinez-Lostao L, Oset M, Muniz-Diaz E, Estivill X, Volpini V, Fillat C. Wiskott-Aldrich syndrome in a female with skewed X-chromosome inactivation. Blood Cells Mol Dis 31:332-337, 2003.
19. Nakanishi K, Iijima K, Kuroda N, Inoue Y, Sado Y, Nakamura H, Yoshikawa N. Comparison of alpha5(IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome. J Am Soc Nephrol 9:1433-1440, 1998.
20. Sharp A, Robinson D, Jacobs P. Age- and tissue-speciffic variation of X chromosome inactivation ratios in normal women. Hum Genet 107:343-349, 2000.
21. Kubota T, Nonoyama S, Tonoki H, Masuno M, Imaizumi K, Kojima M, Wakui K, Shimadzu M, Fukushima Y. A new assay for the analysis of X-chromosome inactivation based on methylation-specific PCR. Hum Genet 104:49-55, 1999.
22. Vetrie D, Flinter F, Bobrow M, Harris A. X inactivation patterns in females with Alport's syndrome: a means of selecting against a deleterious gene? J Med Genet 29:663-666, 1992.
23. Gale RE, Wheadon H, Boulos P, Linch DC. Tissue specificity of X-chromosome inactivation patterns. Blood 83:2899-2905, 1994.
24. Holliday R. DNA methylation and epigenotypes. Biochemistry 70:500-504, 2005.
25. Lund AH, van Lohuizen M. Epigenetics and cancer. Genes Dev 18:2315-2335, 2004.